Press release
Pars Planitis Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032), States DelveInsight | Allergan, EyePoint Pharmaceuticals, Inc., Lux Biosciences, Inc., Clearside Biomedical, Inc., Novartis, Priovant Therapeutics
To Know in detail about the Pars Planitis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Pars Planitis Market Forecast
https://www.delveinsight.com/sample-request/pars-plantis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Pars Planitis Market Report:
• The Pars Planitis market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• Vadot et al. discovered an incidence of 1.4 per 100,000 people in France and a prevalence of 5.9 per 100,000 people in a prospective epidemiological study of 215 uveitis patients. Gritz and Wong discovered an incidence of 1.5 per 100,000 and a prevalence of 4 per 100,000 in the United States
• Pars planitis is an idiopathic inflammatory illness characterised by snowbank accumulation along the pars plana and peripheral retina, exudates, and cells and debris in the vitreous. Patients between the ages of 5 and 40 experience it
• In children and adolescents, pars planitis, an idiopathic chronic intermediate uveitis that makes up 5-26.7% of paediatric uveitis, is most common
• Key Pars Planitis Companies: STZ eyetrial, Allergan, EyePoint Pharmaceuticals, Inc., Lux Biosciences, Inc., Clearside Biomedical, Inc., Novartis, Priovant Therapeutics, Inc., Quantum Cryogenics, Pacira BioSciences, Inc., ATRICURE, INC., BTG International Inc., Zimmer MedizinSysteme GmbH, Medtronic plc, CooperSurgical, Inc., Hologic, Inc., Novartis AG, AstraZeneca, Johnson & Johnson Private Limited, AbbVie Inc., Pfizer Inc., GlaxoSmithKline plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd., Sanofi SA, Aurobindo Pharma co., Cipla Inc., Merck & Co., Inc., and others
• Key Pars Planitis Therapies: Myfortic, Dexamethasone pellet, Sham Injector, LX211, triamcinolone acetonide (Triesence®), LFG316, Brepocitinib, and others
• The Pars Planitis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Pars Planitis pipeline products will significantly revolutionize the Pars Planitis market dynamics.
Pars Planitis Overview
A persistent intermediate uveitis called pars planitis has not been connected with any systemic illness or infection. Although pars planitis patients rarely experience symptoms, they could mention floaters or impaired vision. There is typically no pain or photophobia.
Get a Free sample for the Pars Planitis Market Report
https://www.delveinsight.com/report-store/pars-plantis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Pars Planitis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Pars Planitis Epidemiology Segmentation:
The Pars Planitis market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Pars Planitis
• Prevalent Cases of Pars Planitis by severity
• Gender-specific Prevalence of Pars Planitis
• Diagnosed Cases of Episodic and Chronic Pars Planitis
Download the report to understand which factors are driving Pars Planitis epidemiology trends @ Pars Planitis Epidemiology Forecast
https://www.delveinsight.com/sample-request/pars-plantis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Pars Planitis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Pars Planitis market or expected to get launched during the study period. The analysis covers Pars Planitis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Pars Planitis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Pars Planitis Therapies and Key Companies
• Myfortic: STZ eyetrial
• Dexamethasone pellet: Allergan
• Sham Injector: EyePoint Pharmaceuticals, Inc.
• LX211: Lux Biosciences, Inc.
• triamcinolone acetonide (Triesence®): Clearside Biomedical, Inc.
• LFG316: Novartis
• Brepocitinib: Priovant Therapeutics, Inc.
Discover more about therapies set to grab major Pars Planitis market share @ Pars Planitis Treatment Market
https://www.delveinsight.com/sample-request/pars-plantis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Scope of the Pars Planitis Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Pars Planitis Companies: STZ eyetrial, Allergan, EyePoint Pharmaceuticals, Inc., Lux Biosciences, Inc., Clearside Biomedical, Inc., Novartis, Priovant Therapeutics, Inc., Quantum Cryogenics, Pacira BioSciences, Inc., ATRICURE, INC., BTG International Inc., Zimmer MedizinSysteme GmbH, Medtronic plc, CooperSurgical, Inc., Hologic, Inc., Novartis AG, AstraZeneca, Johnson & Johnson Private Limited, AbbVie Inc., Pfizer Inc., GlaxoSmithKline plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd., Sanofi SA, Aurobindo Pharma co., Cipla Inc., Merck & Co., Inc., and others
• Key Pars Planitis Therapies: Myfortic, Dexamethasone pellet, Sham Injector, LX211, triamcinolone acetonide (Triesence®), LFG316, Brepocitinib, and others
• Pars Planitis Therapeutic Assessment: Pars Planitis current marketed and Pars Planitis emerging therapies
• Pars Planitis Market Dynamics: Pars Planitis market drivers and Pars Planitis market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Pars Planitis Unmet Needs, KOL's views, Analyst's views, Pars Planitis Market Access and Reimbursement
To know more about Pars Planitis companies working in the treatment market, visit @ Pars Planitis Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/pars-plantis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Table of Contents
1. Pars Planitis Market Report Introduction
2. Executive Summary for Pars Planitis
3. SWOT analysis of Pars Planitis
4. Pars Planitis Patient Share (%) Overview at a Glance
5. Pars Planitis Market Overview at a Glance
6. Pars Planitis Disease Background and Overview
7. Pars Planitis Epidemiology and Patient Population
8. Country-Specific Patient Population of Pars Planitis
9. Pars Planitis Current Treatment and Medical Practices
10. Pars Planitis Unmet Needs
11. Pars Planitis Emerging Therapies
12. Pars Planitis Market Outlook
13. Country-Wise Pars Planitis Market Analysis (2019-2032)
14. Pars Planitis Market Access and Reimbursement of Therapies
15. Pars Planitis Market Drivers
16. Pars Planitis Market Barriers
17. Pars Planitis Appendix
18. Pars Planitis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Related Reports:
Pars Planitis Epidemiology https://www.delveinsight.com/report-store/pars-plantis-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Pars Planitis Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Pars Planitis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports by DelveInsight
Monkeypox Market https://www.delveinsight.com/report-store/monkeypox-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Monkeypox Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Monkeypox, historical and forecasted epidemiology as well as the Monkeypox market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Pars Planitis Market
https://www.delveinsight.com/report-store/pars-plantis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Pars Plantis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Pars Plantis, historical and forecasted epidemiology as well as the Pars Plantis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Patient Monitoring Devices Market
https://www.delveinsight.com/report-store/patient-monitoring-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Patient Monitoring Devices Market By Type Of Devices (Neuromonitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Hemodynamic Monitoring Devices, Blood Glucose Monitoring Systems, And Others), By Application (Cardiology, Neurology, Respiratory, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings, And Others), by geography, is anticipated to grow at a significant CAGR till 2028 owing to the growing prevalence of various chronic disorders and integration of advanced technology in the products
Typhoid Market https://www.delveinsight.com/report-store/typhoid-fever-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Typhoid Fever Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Typhoid Fever, historical and forecasted epidemiology as well as the Typhoid Fever market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Zika Virus Market https://www.delveinsight.com/report-store/zika-virus-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Zika Virus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Zika Virus, historical and forecasted epidemiology as well as the Zika Virus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Opioid Use Disorder Market https://www.delveinsight.com/report-store/opioid-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Opioid Use Disorder (OUD) - Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Opioid Use Disorder (OUD), historical and forecasted epidemiology as well as the Opioid Use Disorder (OUD) market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.
Recent Blog's By DelveInsight:
• Insights Into The Cutaneous T-cell Lymphoma Treatment Market
https://www.delveinsight.com/blog/cutaneous-t-cell-lymphoma-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Roche's HEMLIBRA: A Game Changer in Hemophilia A Treatment Landscape
https://www.delveinsight.com/blog/hemlibra-for-hemophilia-a-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Emerging Role of Digital Health in the Field of Oncology
https://www.delveinsight.com/blog/digital-health-to-improve-cancer-management?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How Will Emerging Therapies Drift the Amyotrophic Lateral Sclerosis (ALS) Treatment Landscape
https://www.delveinsight.com/blog/evolving-als-treatment-landscape?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How are Technological Trends and Innovations Reshaping the Dementia Care
https://www.delveinsight.com/blog/technological-innovations-in-dementia-care?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Assessing the Major Growth and Ongoing Developments in the Clinical Diagnostics Market
https://www.delveinsight.com/blog/clinical-diagnostics-market-outlook?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Non-opioid Analgesics Chronic Pain Treatment: Savior of Underserved Patients
https://www.delveinsight.com/blog/non-opioid-analgesics-for-chronic-pain-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Limited Availability and Lack of Access are Unlikely to Hinder the Billion-Dollar Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market
https://www.delveinsight.com/blog/alpha-1-antitrypsin-deficiency-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Evaluating the Key Trends and Technologies Shaping the Future of Dentistry https://www.delveinsight.com/blog/emerging-trends-in-dental-care-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pars Planitis Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032), States DelveInsight | Allergan, EyePoint Pharmaceuticals, Inc., Lux Biosciences, Inc., Clearside Biomedical, Inc., Novartis, Priovant Therapeutics here
News-ID: 3116581 • Views: …
More Releases from DelveInsight Business Research
DelveInsight Unveils Comprehensive Epidemiology Assessment of Cutaneous Squamous …
DelveInsight, a global leader in healthcare research and analytics, announces the release of its in-depth Cutaneous Squamous Cell Carcinoma (cSCC) Epidemiology Assessment, providing unparalleled insights into the prevalence of cSCC among solid organ transplant recipients across 15 countries, including the United States, key European nations, and select countries in the Asia-Pacific (APAC) region.
The newly released assessment delivers country-specific epidemiological insights aimed at guiding strategic decision-making for pharmaceutical companies, healthcare providers,…
Unlocking Market Potential: DelveInsight's Comprehensive Patent Foramen Ovale (P …
DelveInsight's Market Size & Forecast Assessment Provides Data-Driven Insights for Patient-Centric Market Expansion Strategies
DelveInsight, a leading healthcare market research and consulting firm, has released an in-depth case study highlighting its latest assessment of the Patent Foramen Ovale (PFO) Device Market across the European Union. This strategic market intelligence report provides a holistic understanding of the patient population, device market size, competitor landscape, and reimbursement scenario, equipping medical device companies with…
Global Chronic Obstructive Pulmonary Disease Treatment Devices Market Poised for …
The Chronic Obstructive Pulmonary Disease (COPD) Treatment Devices Market is set for strong expansion, projected to grow at a CAGR of 6.35% from 2025 to 2032, according to recent industry findings. This growth is primarily fueled by the increasing global prevalence of COPD, escalating exposure to tobacco smoke and air pollution, expanding screening programs, and the rapid development of next-generation respiratory devices such as portable nebulizers and smart inhalers.
The global…
CD40 Pipeline 2025: FDA Approvals and Clinical Trials Landscape with MOA and ROA …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, CD40 pipeline constitutes key companies continuously working towards developing CD40 treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"CD40 Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the CD40 Market.
The CD40 Pipeline report embraces in-depth commercial and…
More Releases for Pars
Pars Planitis Market Forecast to Grow at 6.5% CAGR, Reaching USD 780 Million by …
Introduction
Pars planitis is a rare, idiopathic inflammatory condition of the eye that primarily affects the pars plana region of the ciliary body. Classified as a subset of intermediate uveitis, it typically impacts children and young adults and is characterized by floaters, blurred vision, and vitreous opacities. Although not life-threatening, untreated pars planitis can lead to complications such as macular edema, cataracts, or retinal detachment, significantly affecting quality of life.
Over the…
Pars Planitis Market Dynamics Indicate Upward Trajectory Through 2032, Reports D …
DelveInsight's "Pars Planitis Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Pars Planitis, historical and forecasted epidemiology as well as the Pars Planitis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Pars Planitis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Pars Planitis Market Forecast
https://www.delveinsight.com/sample-request/pars-plantis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Global Pars Planitis Treatment Market Achieves Significant Growth in 2022 and Fo …
In 2022, the global Pars Planitis treatment market attained a valuation of US$ YY billion, with projections to reach US$ YY billion by 2030. The market is set to experience a robust Compound Annual Growth Rate (CAGR) of YY% during the forecast period spanning from 2023 to 2030.
The global Pars Planitis treatment market has undergone notable growth and transformations, driven by various factors shaping its dynamics. Pars Planitis, a persistent…
Pars Planitis Market Growth Elements, Recent Developments, and Key Players Strat …
Pars Planitis Market 2023 by Technology, Manufacturers, Regions, Type, and Application, Forecast guide to light the excellent analysis on the market synopsis. The report offers a primary focus on important factors in the global Pars Planitis industry. The report includes perceptive information about gross revenue, cost, value, capacity, pricing, and profit margins concerning historical analysis and forecast estimation for the 2023 to 2031 time period. It presents a close overview…
Global Styrene Market 2017 - Shell, Total, SINOPEC, BASF, Versalis, Pars
Global Styrene market Report offers decisive insights into the overall Styrene industry along with the market dimensions and evaluation for the duration 2017 to 2022. The forenamed research study covers extensive analysis of various Styrene industry segments based on the type of applications, type of product Components and services, and different geographical regions.
Styrene, also known as ethenylbenzene, vinylbenzene, and phenylethene, is an organic compound with the chemical formula C6H5CH=CH2.…
Dental Clinic Cabinet Global Market 2017 by Manufacturers - Sirona, Pars Dental, …
Global Dental Clinic Cabinet Market 2017, presents a professional and in-depth study on the current state of the Dental Clinic Cabinet market globally, providing basic overview of Dental Clinic Cabinet market including Definitions, Classifications, Applications and Industry chain structure, Dental Clinic Cabinet Market report provides development policies and plans are discussed as well as manufacturing processes and cost structures. Dental Clinic Cabinet market size, share and end users are analyzed…
